These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 4549351

  • 1. Quantitative evaluation of the effectiveness of Connaught freeze-dried BCG vaccine in mice and in guineapigs.
    Siebenmann CO, Barbara C.
    Bull World Health Organ; 1974; 51(3):283-9. PubMed ID: 4549351
    [Abstract] [Full Text] [Related]

  • 2. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 3. [Comparative study of BCG vaccines: Polish, Danish and Japanese -- laboratory tests].
    Janaszek W.
    Przegl Epidemiol; 1994 Dec; 48(3):285-92. PubMed ID: 7938633
    [Abstract] [Full Text] [Related]

  • 4. Comparison of freeze-dried vaccines prepared from four different strains of BCG.
    Landi S, Barbara C, Przykuta K, Held HR.
    Dev Biol Stand; 1994 Dec; 38():19-28. PubMed ID: 608506
    [Abstract] [Full Text] [Related]

  • 5. Studies on the biological activity of two strains of BCG: influence of production conditions.
    Chouchkova M, Engibarov A.
    Dev Biol Stand; 1986 Dec; 58 ( Pt A)():105-18. PubMed ID: 3297858
    [Abstract] [Full Text] [Related]

  • 6. Optimal models to evaluate the protective efficacy of tuberculosis vaccines.
    Griffin JF, Chinn DN, Rodgers CR, Mackintosh CG.
    Tuberculosis (Edinb); 2001 Dec; 81(1-2):133-9. PubMed ID: 11463234
    [Abstract] [Full Text] [Related]

  • 7. Stabilisation of BCG vaccines.
    Gheorghiu M, Lagranderie M, Balazuc AM.
    Dev Biol Stand; 1996 Dec; 87():251-61. PubMed ID: 8854025
    [Abstract] [Full Text] [Related]

  • 8. The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs.
    Martin C, Williams A, Hernandez-Pando R, Cardona PJ, Gormley E, Bordat Y, Soto CY, Clark SO, Hatch GJ, Aguilar D, Ausina V, Gicquel B.
    Vaccine; 2006 Apr 24; 24(17):3408-19. PubMed ID: 16564606
    [Abstract] [Full Text] [Related]

  • 9. Theoretical and methodological aspects of BCG vaccine from the discovery of Calmette and Guérin to molecular biology. A review.
    Lugosi L.
    Tuber Lung Dis; 1992 Oct 24; 73(5):252-61. PubMed ID: 1493232
    [Abstract] [Full Text] [Related]

  • 10. [Comparative studies of 5 BCG substrains. 3. Anti-tuberculous resistance acquired by BCG vaccination with 5 vaccines of different origins].
    Paraschivesco M, Gheorghiu M, Bonciu C, Petrovici M, Rîmniceanu I.
    Arch Roum Pathol Exp Microbiol; 1969 Oct 24; 28(2):545-8. PubMed ID: 5400045
    [No Abstract] [Full Text] [Related]

  • 11. [Protective efficacy of BCG Tokyo 172 in the guinea pig model of pulmonary tuberculosis].
    Yamamoto T, Phalen S, Uchida K, Umemori K, Nojima Y, Horiuchi Y, Goto Y, McMurray DN, Yamamoto S.
    Kekkaku; 2000 May 24; 75(5):379-88. PubMed ID: 10853313
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. EXPERIMENTAL studies of vaccination, allergy, and immunity in tuberculosis. II. Effect of varying the dose of BCG.
    Tuberculosis Program, Public Health Service.
    Bull World Health Organ; 1955 May 24; 12(1-2):31-45. PubMed ID: 14351967
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Perspectives for BCG standardization.
    Lévy FM, Mande R, Conge G, Fillastre C, Orssaud E.
    Bibl Tuberc; 1968 May 24; 24():63-190. PubMed ID: 4984263
    [No Abstract] [Full Text] [Related]

  • 17. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M, Shirakawa T.
    Kekkaku; 2005 Sep 24; 80(9):613-29. PubMed ID: 16245793
    [Abstract] [Full Text] [Related]

  • 18. Assessment of different formulations of oral Mycobacterium bovis Bacille Calmette-Guérin (BCG) vaccine in rodent models for immunogenicity and protection against aerosol challenge with M. bovis.
    Clark S, Cross ML, Smith A, Court P, Vipond J, Nadian A, Hewinson RG, Batchelor HK, Perrie Y, Williams A, Aldwell FE, Chambers MA.
    Vaccine; 2008 Oct 29; 26(46):5791-7. PubMed ID: 18789366
    [Abstract] [Full Text] [Related]

  • 19. Further studies on BCG vaccine prepared by tween 80 method with particular reference to effect of freeze-drying.
    TAKANO K, OBAYASHI Y, NOGUCHI T.
    Bull World Health Organ; 1957 Oct 29; 17(2):295-306. PubMed ID: 13489470
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.